Press Releases

 

[email protected]
+972 58 6683040 Whatsapp
1 416 467 5229 Canada
972 77 4442333 Israel
972 77 4442331 Fax

18/11/2021 IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction
15/11/2021 Management’s Discussion and Analysis
15/11/2021 IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update
08/09/2021 News Release Announcing Second Share Issuance re Panaxia Transaction
16/08/2021 News Release Announcing 2Q Results for Financial Period Ending June 30, 2021
09/08/2021 News Release Announcing LOI with cbdMD Inc. and Panaxia Share Issuance
03/08/2021 News Release Announcing Annual Meeting Voting Results
28/07/2021 IMC Accelerates its Israel Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way
23/07/2021 PR - IM Cannabis Provides Update on German Operations and Financial Outlook
13/07/2021 PR - IM Cannabis Provides Business, Legal and Regulatory Update
09/07/2021 PR - IM Cannabis Closes Acquisition of MYM Nutraceuticals
06/07/2021 Press Release - MYM Shareholders Overwhelmingly Approve Plan of Arrangement with IM Cannabis
28/06/2021 PR -IM Cannabis Proposed Acquisition of MYM Receives Positive Recommendations from Proxy Advisory Firms
17/06/2021 Press Release - IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions
07/06/2021 Press Release - IM Cannabis Announces Supply Agreement with Flowr Corporation
01/06/2021 Press Release - IMC Reports First Closing of the Panaxia Acquisition and Provides Update on Canada Business Activities
17/05/2021 Press Release - IM Cannabis Reports Record Q1 2021 Results
10/05/2021 Press Release IM Cannabis Announces Closing of US$ 35 Million Equity Financing
05/05/2021 Press Release - IM Cannabis Announces Pricing of Proposed Public Offering of Securities
04/05/2021 Press Release - IM Cannabis Announces Proposed Public Offering of Securities
30/04/2021 Press Release - IM Cannabis Acquires Israel's Largest Retail and Online Pharmacy Business from Panaxia
23/04/2021 News Release Announcing Fiscal 2020 Results
13/04/2021 Press Release - Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market
12/04/2021 Press Release - IM Cannabis Provides Update on Adjupharm Business Developments in Germany
05/04/2021 Press Release - IM Cannabis to Acquire MYM Nutraceuticals
31/03/2021 Press Release - IMC Announces Filing of Final Short Form Base Shelf Prospectus
18/03/2021 IMC Closes Acquisition of Trichome, Establishing Global Growth Platform in Both Adult Use and Medical Cannabis Markets
12/03/2021 IMC Announces Filing of Preliminary Short Form Base Shelf Prospectus
08/03/2021 IMC to Bring Canadian Premium Indoor High-THC Medical Cannabis to Israel with Imports from GTEC
01/03/2021 IM Cannabis Corp. Becomes First Israeli Medical Cannabis Operator to list on NASDAQ; Trading Today Under Symbol “IMCC”
25/02/2021 IM Cannabis Common Shares Expected to Begin Trading on NASDAQ on March 1, 2021
22/02/2021 IMC Announces Additions to Board to Satisfy NASDAQ Director Independence Requirements
16/02/2021 IMC Common Shares Commences Trading on Consolidated Basis
10/02/2021 IMC Announces Details of Share Consolidation to Meet NASDAQ Capital Market Listing Requirement
26/01/2021 IM Cannabis Receives DTC Eligibility as Part of NASDAQ Capital Market Listing Approval Process
12/01/2021 IM Cannabis Releases Message from CEO and 2021 Outlook